July 11, 2017Open Access

Resource implications of preparing individual participant data from a clinical trial to share with external researchers

Key Points

Key points are not available for this paper at this time.

Abstract

EU Clinical Trials Register Eudract 2006-004025-28 . Registered on 16 May 2007. International Standard Randomised Controlled Trials Registry: ISRCTN05534585 /MREC 07/MRE08/43. Registered on 26 January 2007.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Smith et al. (Tue,) studied this question.

synapsesocial.com/papers/69d80a2a5c3030ff03d18c8c https://doi.org/https://doi.org/10.1186/s13063-017-2067-4

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).2012 · 95 citations
2Sharing data from clinical trials: the rationale for a controlled access approach2015 · 72 citations
3The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial2007 · 977 citations
4A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial2007 · 110 citations
5Sharing all types of clinical data and harmonizing journal standards2016 · 36 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper